Thanks Eshan for excellent issue #103! Your great work gives me hope and encouragement that one day in the foreseeable future we will see alt protein products widely available as a consumer options to factory farmed meat. I like your use of helpful graphics in #103. Keep up the outstanding job and have a very nice and peaceful week 👍❤️
Thank you so much for the kind words and encouragement! It means a lot to know the newsletter is helping spark hope for a better food system. Wishing you a peaceful and inspiring week ahead too!
Given your interest in Biotech/biomanufacturing, you might enjoy my recent piece on eXoZymes Inc. They’ve just commercially launched a cell-free enzyme biocatalysis platform that converts biofeedstocks into targeted chemical products.
Plus they just announced their first subsidary which synthesises N-trans-caffeoyltyramine (NCT) to treat MASLD/MASH. Very very interesting compound that has immense potential. This is just the first of many asset compounds in the nutraceutical/API/industrial/food flavours/fragrances space.
Thanks Eshan for excellent issue #103! Your great work gives me hope and encouragement that one day in the foreseeable future we will see alt protein products widely available as a consumer options to factory farmed meat. I like your use of helpful graphics in #103. Keep up the outstanding job and have a very nice and peaceful week 👍❤️
Thank you so much for the kind words and encouragement! It means a lot to know the newsletter is helping spark hope for a better food system. Wishing you a peaceful and inspiring week ahead too!
Hey team!
Given your interest in Biotech/biomanufacturing, you might enjoy my recent piece on eXoZymes Inc. They’ve just commercially launched a cell-free enzyme biocatalysis platform that converts biofeedstocks into targeted chemical products.
Plus they just announced their first subsidary which synthesises N-trans-caffeoyltyramine (NCT) to treat MASLD/MASH. Very very interesting compound that has immense potential. This is just the first of many asset compounds in the nutraceutical/API/industrial/food flavours/fragrances space.
https://www.slack-capital.com/p/exozymes-research-report